A Study to Assess Safety, Tolerability and Pharmacokinetics of Transdermal SFG-02 in Healthy Participants

NCT07167914 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Participants

Interventions

DRUG: SFG-02
DRUG: Placebo

Sponsor

Juro Sciences Inc.